Literature DB >> 1280057

Azithromycin-induced block of elementary body formation in Chlamydia trachomatis.

J N Engel1.   

Abstract

The mechanism of action of azithromycin on the murine strain of Chlamydia trachomatis grown in tissue culture epithelial cells is addressed. Azithromycin at a concentration of 100 ng/ml inhibits chlamydial growth in tissue culture, a value that agrees well with prior in vitro data from human strains of C. trachomatis grown in tissue culture. By morphological criteria, the block to chlamydial growth appears to occur early in its life cycle. Azithromycin is not directly toxic to chlamydial elementary bodies but does inhibit chlamydial protein synthesis in chlamydia-infected cells. This inhibition appears quite general in nature and is rapid. It is further shown that azithromycin does not directly inhibit mRNA synthesis. Azithromycin blocks chlamydial protein synthesis in host cell-free chlamydial reticulate bodies in a manner similar to its inhibition in infected cells, albeit at slightly higher concentrations. The inhibition of chlamydial protein synthesis following a brief exposure to azithromycin is more long lasting than that following a brief exposure to erythromycin.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1280057      PMCID: PMC245493          DOI: 10.1128/AAC.36.10.2304

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  16 in total

Review 1.  Interaction of chlamydiae and host cells in vitro.

Authors:  J W Moulder
Journal:  Microbiol Rev       Date:  1991-03

2.  The role of azalide antibiotics in the treatment of Chlamydia.

Authors:  R B Johnson
Journal:  Am J Obstet Gynecol       Date:  1991-06       Impact factor: 8.661

3.  Chlamydial rRNA operons: gene organization and identification of putative tandem promoters.

Authors:  J N Engel; D Ganem
Journal:  J Bacteriol       Date:  1987-12       Impact factor: 3.490

4.  Developmental regulation of the cysteine-rich outer-membrane proteins of murine Chlamydia trachomatis.

Authors:  L M Sardinia; E Segal; D Ganem
Journal:  J Gen Microbiol       Date:  1988-04

Review 5.  Chlamydiae.

Authors:  J Schachter; H D Caldwell
Journal:  Annu Rev Microbiol       Date:  1980       Impact factor: 15.500

6.  Maturation of the head of bacteriophage T4. I. DNA packaging events.

Authors:  U K Laemmli; M Favre
Journal:  J Mol Biol       Date:  1973-11-15       Impact factor: 5.469

7.  Azithromycin in the treatment of sexually transmitted disease.

Authors:  O Steingrimsson; J H Olafsson; H Thorarinsson; R W Ryan; R B Johnson; R C Tilton
Journal:  J Antimicrob Chemother       Date:  1990-01       Impact factor: 5.790

8.  In vitro and in vivo uptake of azithromycin (CP-62,993) by phagocytic cells: possible mechanism of delivery and release at sites of infection.

Authors:  R P Gladue; G M Bright; R E Isaacson; M F Newborg
Journal:  Antimicrob Agents Chemother       Date:  1989-03       Impact factor: 5.191

9.  Chlamydia trachomatis has penicillin-binding proteins but not detectable muramic acid.

Authors:  A G Barbour; K Amano; T Hackstadt; L Perry; H D Caldwell
Journal:  J Bacteriol       Date:  1982-07       Impact factor: 3.490

10.  Electron microscopic observations on the effects of penicillin on the morphology of Chlamydia psittaci.

Authors:  A Matsumoto; G P Manire
Journal:  J Bacteriol       Date:  1970-01       Impact factor: 3.490

View more
  4 in total

1.  Novel Detection Strategy To Rapidly Evaluate the Efficacy of Antichlamydial Agents.

Authors:  Yan Zhang; Yuqi Xian; Leiqiong Gao; Hiba Elaasar; Yao Wang; Lamiya Tauhid; Ziyu Hua; Li Shen
Journal:  Antimicrob Agents Chemother       Date:  2017-01-24       Impact factor: 5.191

2.  Andrographolide inhibits intracellular Chlamydia trachomatis multiplication and reduces secretion of proinflammatory mediators produced by human epithelial cells.

Authors:  Ziyu Hua; Kyla M Frohlich; Yan Zhang; Xiaogeng Feng; Jiaxing Zhang; Li Shen
Journal:  Pathog Dis       Date:  2014-12-17       Impact factor: 3.166

Review 3.  Membrane vesicle production by Chlamydia trachomatis as an adaptive response.

Authors:  Kyla M Frohlich; Ziyu Hua; Alison J Quayle; Jin Wang; Maria E Lewis; Chau-wen Chou; Miao Luo; Lyndsey R Buckner; Li Shen
Journal:  Front Cell Infect Microbiol       Date:  2014-06-10       Impact factor: 5.293

Review 4.  Will the SAFE strategy be sufficient to eliminate trachoma by 2020? Puzzlements and possible solutions.

Authors:  Diane K Lavett; Van C Lansingh; Marissa J Carter; Kristen A Eckert; Juan C Silva
Journal:  ScientificWorldJournal       Date:  2013-05-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.